CLEARWATER, Fla., Feb. 23, 2026 (GLOBE NEWSWIRE) — via IBN — MedWell Ai, Inc, (OTCQB:MWAI) (“Company”) is a portfolio company, specializing in AI-driven solutions for B2B markets in pharmaceuticals, healthcare, and wellness, is pleased to confirm the filing, after the market close, of its Quarterly Report (Form 10-Q), for the financial period, ending on December 31, 2025.
The Company reported $548,315 in Revenue for its fiscal second quarter of 2025. This performance was result of a successful strategic shift toward building an AI-driven healthcare, pharmaceutical and biological wellness portfolio.
Key Financial Highlights:
Increased Total Revenues:
- For three months, ended December 31, 2025, Company had generated total revenues of 548,315 vs $142,861 for three months, ended December 31, 2024 (280%+ increase).
- For six months, ended December 31, 2025, Company had generated total revenues of $1,075,806 vs $144,009 for six months, ended December, 2024 (700%+ increase).
Reduced Total Loss From Operations:
- For three months, ended December 31, 2025, Company’s net loss was reduced to $266,221 vs $315,096 for three months, ended December 31, 2024.
- For six months, ended December …